Edition:
United States

Halozyme Therapeutics Inc (HALO.OQ)

HALO.OQ on NASDAQ Stock Exchange Global Select Market

18.09USD
22 Jun 2018
Change (% chg)

$-0.50 (-2.69%)
Prev Close
$18.59
Open
$18.67
Day's High
$18.73
Day's Low
$17.94
Volume
1,103,904
Avg. Vol
303,165
52-wk High
$21.47
52-wk Low
$11.43

Select another date:

Thu, May 10 2018

BRIEF-Halozyme Reports Q1 Loss Per Share $0.19

* Q1 EARNINGS PER SHARE VIEW $-0.22 -- THOMSON REUTERS I/B/E/S

BRIEF-Halozyme Therapeutics Says CEO Helen Torley's 2017 Compensation Was $5.18 Mln ‍​

* HALOZYME THERAPEUTICS INC SAYS CEO HELEN I. TORLEY'S 2017 TOTAL COMPENSATION WAS $5.18 MILLION VERSUS $4.85 MILLION IN 2016 – SEC FILING‍​ Source text - https://bit.ly/2udFEM8 Further company coverage:

BRIEF-Halozyme Reports Q4 Earnings Per Share $0.85

* REITERATED 2018 FINANCIAL GUIDANCE FOR NET REVENUE OF $115 MILLION TO $125 MILLION Source text for Eikon: Further company coverage:

BRIEF-Halozyme Projects 25 To 30 Percent Enhanze Royalty Growth In 2018

* HALOZYME PROJECTS 25 TO 30 PERCENT ENHANZE ROYALTY GROWTH IN 2018

Select another date: